Identification of sexual networks through molecular typing of quinolone-resistant Neisseria gonorrhoeae in Ontario, Canada

Sexually Transmitted Diseases

Volumn 38, Issue 9, 2011, Pages 811-814

  Ota, Kaede V ^a   Ng, Lai King ^b   Melano, Roberto G ^c,d,e   Martin, Irene E ^b   Brown, Elizabeth M ^d   Richardson, Susan E ^c,d,f   Fisman, David N ^g   Low, Donald E ^c,d,e   Jamieson, Frances B ^c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d PUBLIC HEALTH ONTARIO   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLONE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANADA; HUMAN; MALE HOMOSEXUAL; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NEISSERIA GONORRHOEAE; NEISSERIA GONORRHOEAE MULTIANTIGEN SEQUENCE TYPING; PREVALENCE; QUINOLONE RESISTANT NEISSERIA GONORRHOEAE; SEXUAL TRANSMISSION; SEXUAL TRANSMISSION NETWORK;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GONORRHEA; HOMOSEXUALITY, MALE; HUMANS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; NEISSERIA GONORRHOEAE; ONTARIO; QUINOLONES; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 80051800832     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31821fc7ba     Document Type: Article

References (29)

1. Ota KV, Jamieson F, Fisman DN, et al. Prevalence of and risk factors for quinolone resistant Neisseria gonorrhoeae in Ontario. CMAJ 2009;180:287-290.
2. Santé et Services Sociaux, Gouvernement du Quebec. Augmentation du nombre de souches de Neisseria gonorrhoeae resistantes aux fluoroquinolones au Quebec. Available at: http://publications. msss.gouv. qc.ca/acrobat/f/ documentation/2007/07-342-01.pdf. Accessed August 15, 2010.
3. Plitt S, Boyington C, Sutherland K, et al. Antimicrobial resistance in gonorrhea: the influence of epidemiologic and laboratory surveillance data on treatment guidelines: Alberta, Canada 2001-2007. Sex Transm Dis 2009;36:665-669.
4. Tapsall JW, Limnios EA, Abu Bakar HM, et al. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008. Commun Dis Intell 2010;34:1-7.
5. Statistics Canada. Population and dwelling counts, for Canada, Provinces and Territories, and census divisions, 2006 and 2001 censuses. Available at: http://www12.statcan. ca/english/census06/data/popdwell/Table.cfm?T=702&PR= 35&SR=1&S=3&O=D. Accessed August 15, 2010.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial susceptibility Testing; Twenty-First Informational supplement. CLSI document M100-S21. Wayne, PA: Laboratory Standards Institute; 2011.
7. Health Protection Agency, GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2007 report. Available at: http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1221117895841. Accessed August 15, 2010.
8. Ehret JM, Nims LJ, Judson FN. A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin. Sex Transm Dis 1996;23:270-272. (Pubitemid 26250660)
9. NG-MAST. NG-MAST Neisseria gonorrhoeae multi antigen sequence typing. Available at: http://www.ng-mast.net/misc/info. asp. Accessed August 15, 2010.
10. Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections, 2006 revised edition. Available at: http://www.phac- aspc.gc.ca/std-mts/sti-its/guide-lignesdir-eng.php. Accessed April 30, 2011.
11. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. Morb Mortal Wkly Rep 2007;56:332-336.
12. Martin IMC, Ison CA, Aanensen DM, et al. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London. J Infect Dis 2005;192:1191-1195. (Pubitemid 41368418)
13. Choudhury B, Risley CL, Ghani AC, et al. Identification of individuals within sexual networks: a population-based study. Lancet 2006;368:139-146. (Pubitemid 43994172)
14. Todd K, Durrheim D, Pickles R. Using epidemiological and molecular methods to investigate an outbreak of gonorrhoea associated with heterosexual contact in Newcastle, NSW, Australia. Sex Health 2007;4:233-236. (Pubitemid 350158751)
15. Bauer HM, Mark KE, Samuel M, et al. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003. Clin Infect Dis 2005;41:295-803.
16. Morris SR, Moore DF, Hannah PB, et al. Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak. J Clin Microbiol 2009;47:2944-2949.
17. Wong WW, Huang CT, Li LH, et al. Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis. J Clin Microbiol 2008;46:3931-3934.
18. Palmer HM, Young H, Martin IMC, et al. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis. Sex Transm Infect 2005;81:403-407. (Pubitemid 41494355)
19. Morris SR, Knapp JS, Moore DF, et al. Using strain typing to characterize a fluoroquinolone-resistant Neisseria gonorrhoeae transmission network in southern California. Sex Transm Infect 2008;84:290-291.
20. Tapsall JW, Limnios EA, Shultz TR. Continuing evolution of the pattern of quinolone resistance in Neisseria gonorrhoeae in Sydney Australia. Sex Transm Dis 1998;25:415-417. (Pubitemid 28446749)
21. Tapsall JW, Limnios EA, Murphy D. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997-2006. J Antimicrob Chemother 2008;61:150-155.
22. Tapsall JW, Phillips EA, Shultz TR, et al. Quinolone resistant Neisseria gonorrhoeae isolated in Sydney, Australia 1991-1995. Sex Transm Dis 1996;23:425-428.
23. Tapsall JW, Shultz TR, Phillips EA. Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibiotics. Pathology 1992;24:27-31.
24. Tapsall J. Multi-drug resistant Neisseria gonorrhoeae. CMAJ 2009;180:268-269.
25. Hansfield HH, Rice RJ, Roberts MC, et al. Localized outbreak of penicillinase-producing Neisseria gonorrheoae. JAMA 1989;261:2357-2361.
26. Martin IM, Ison CA, Aanensen DM, et al. Rapid sequence-based identification of gonococcal transmission cluster in a large metropolitan area. J Infect Dis 2004;189:1497-1505. (Pubitemid 38552358)
27. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother 2009;10:1-23.
28. Workowski KA, Berman SM, Douglas JM. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med 2008;148:606-613. (Pubitemid 351669134)
29. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther 2006;4:619-628. (Pubitemid 44523940)